Fri Sep 20 08:42:54 UTC 2024: ## Dr. Martens Stock Plunges to New 52-Week Low
**London, UK – September 20, 2024** – Dr. Martens plc (LON:DOCS) shares plummeted to a new 52-week low on Friday, closing at GBX 56 ($0.74) after hitting a low of GBX 54.40 ($0.72). The stock’s decline comes amid broader market concerns and follows a recent insider purchase of 25,000 shares by Lynne Weedall, a company director.
The stock’s performance contrasts with the company’s strong financial fundamentals, including a current ratio of 2.85 and a quick ratio of 1.13. However, Dr. Martens’ high debt-to-equity ratio of 129.55 may be contributing to investor concerns.
Despite the stock’s recent decline, insiders remain confident in the company’s future, evidenced by the recent insider purchase. Over the last ninety days, insiders have acquired a total of 25,426 shares, worth $1,880,142. Insiders currently own 4.36% of the company’s stock.
Dr. Martens, a leading footwear brand known for its iconic boots, continues to operate across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company offers a range of footwear products under the Dr. Martens brand name, including originals, fusion, kids, and casual styles, alongside accessories.
While the stock’s current performance reflects market uncertainty, Dr. Martens remains a well-established brand with a solid track record. The company’s long-term outlook remains positive, and investors may be anticipating a rebound in the near future.
First Piper 